CSIMarket
 


Tauriga Sciences Inc   (TAUG)
Other Ticker:  
 

Cumulative Tauriga Sciences Inc 's Working Capital Ratio for Trailing Twelve Months Period

TAUG's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

TAUG Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2021)
III. Quarter
(Sep 30 2021)
II. Quarter
(Jun 30 2021)
I. Quarter
(Mar 31 2021)
IV. Quarter
(Dec 31 2020)
III. Quarter
Y / Y Current Liabilities Growth 67.26 % 99.46 % 38.72 % 23.84 % 74.71 %
Y / Y Current Assets Growth -32.17 % 89.42 % 195.11 % 294.24 % 249.62 %
Working Capital Ratio for Trailing Twelve Months Period 1.27 1.6 1.72 1.47 1.13
Total Ranking # 3900 # 2763 # 2554 # 2946 # 3407
Seq. Current Liabilities Growth 19.15 % 36.56 % 18.4 % -13.18 % 42.09 %
Seq. Current Assets Growth -18.79 % -29.04 % 11.35 % 5.7 % 126.8 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2021
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $2 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 1.27 below Tauriga Sciences Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Legal Cannabis industry 15 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Tauriga Sciences Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about TAUG
Working Capital Ratio TAUG in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 16
Sector # 181
S&P 500 # 4975


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.5 1.14 0
(Sep 30 2018)   (Mar 31 2017)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2021, within Legal Cannabis Industry Working Capital Ratio for Trailing Twelve Months Period
Natural Alternatives International Inc  3.29 
Mediwound Ltd   3.17 
Cyanotech Corp  2.82 
Chromadex Corporation  2.75 
Usana Health Sciences Inc   2.40 
Upexi Inc   2.30 
Bon Natural Life Limited  2.27 
Healthy Extracts Inc   2.23 
Tilray Brands Inc   1.96 
Mannatech Incorporated  1.40 
Biote Corp   1.24 
Tauriga Sciences Inc   1.22 
Alterola Biotech Inc   1.00 
4front Ventures Corp   1.00 
Hero Technologies Inc  0.89 
Pure Harvest Corporate Group Inc   0.71 
Panacea Life Sciences Holdings Inc   0.66 
Cat9 Group Inc   0.60 
Charlie s Holdings Inc   0.50 
Akanda Corp   0.48 
Stem Holdings Inc   0.47 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com